Join the 200th Anniversary Celebration

Original Article

Enhanced Detection of Ischemic but Viable Myocardium by the Reinjection of Thallium after Stress-Redistribution Imaging

Vasken Dilsizian, M.D., Thomas P. Rocco, M.D., Nanette M.T. Freedman, Ph.D., Martin B. Leon, M.D., and Robert O. Bonow, M.D.

N Engl J Med 1990; 323:141-146July 19, 1990

Abstract
Abstract

Background.

The identification of ischemic but viable myocardium by thallium exercise scintigraphy is often imprecise, since many of the perfusion defects that develop in ischemic myocardium during exercise do not "fill in" on subsequent redistribution images. We hypothesized that a second injection of thallium given after the redistribution images were taken might improve the detection of ischemic but viable myocardium.

Methods.

We studied 100 patients with coronary artery disease, using thallium exercise tomographic imaging and radionuclide angiography. Patients received 2 mCi of thallium intravenously during exercise, redistribution imaging was performed three to four hours later, and a second dose of 1 mCi of thallium was injected at rest immediately thereafter. The three sets of images (stress, redistribution, and reinjection) were then analyzed.

Results.

Ninety-two of the 100 patients had exercise-induced perfusion defects. Of the 260 abnormal myocardial regions identified by stress imaging, 85 (33 percent) appeared to be irreversible on redistribution imaging three to four hours later. However, 42 of these apparently irreversible defects (49 percent) demonstrated improved or normal thallium uptake after the second injection of thallium, with an increase in mean regional uptake from 56± 12 percent on redistribution studies to 64± 10 percent on reinjection imaging (P<0.001). Twenty patients were restudied three to six months after coronary angioplasty. Of the 15 myocardial regions with defects on redistribution studies that were identified as viable by reinjection studies before angioplasty, 13 (87 percent) had normal thallium uptake and improved regional wall motion after angioplasty. In contrast, all eight regions with persistent defects on reinjection imaging before angioplasty had abnormal thallium uptake and abnormal regional wall motion after angioplasty.

Conclusions.

These data indicate that the reinjection of thallium improves the detection of ischemic myocardium and that myocardial regions with improved thallium uptake on reinjection imaging represent viable but jeopardized myocardium. (N Engl J Med 1990; 323:141–6.)

Media in This Article

Figure 1Sector Analysis for Assessing the Regional Uptake of Thallium by the Myocardium.
Figure 2Short-Axis Thallium Tomograms during Stress, Redistribution, and Reinjection Imaging in a Patient with Coronary Artery Disease.
Article

IN many patients with coronary artery disease, impaired left ventricular systolic function at rest is caused by regionally ischemic or "hibernating" myocardium rather than irreversibly damaged myocardium.1 , 2 In such patients, left ventricular function will improve after revascularization.3 4 5 6 However, the identification of patients with such potentially reversible left ventricular dysfunction has been difficult.

Myocardial perfusion imaging with thallium-201 is a clinically important adjunct to exercise testing for the evaluation of patients with coronary artery disease.7 , 8 Thallium imaging is of value in detecting viable myocardium when regions with perfusion defects during exercise (stress imaging) demonstrate "redistribution" of the isotope on images obtained three to four hours later at rest (redistribution imaging). In many regions of viable myocardium, however, defects that are detected during thallium exercise testing persist and appear to be irreversible on images taken at rest three to four hours later.9 10 11 Thus, standard thallium scintigraphy may not always distinguish between regions of infarcted or ischemic myocardium in patients with left ventricular dysfunction.

The redistribution of thallium ("filling in") in a given defect may depend not only on the severity of the perfusion abnormality detected during exercise testing, but also on the subsequent levels of thallium in the blood. We hypothesized that the reinjection of thallium immediately after redistribution imaging might augment the blood concentration of the isotope to facilitate myocardial uptake in such viable regions. Thus, reinjection would provide an opportunity to compare relative perfusion under stress and resting conditions.

Methods

Selection of Patients

We studied 100 patients with coronary artery disease. A history and chest x-ray film were obtained for all patients, and all patients underwent physical examination, electrocardiography, coronary arteriography, radionuclide angiography, and exercise thallium single-photon-emission computed tomography (SPECT). Coronary artery disease was defined as a reduction ≥50 percent in the luminal diameter of at least one major epicardial coronary artery as determined by coronary angiography. All cardiac medications were withdrawn before exercise studies in 66 percent of the patients. These protocol studies were approved by the Institutional Clinical Research Subpanel of the National Heart, Lung, and Blood Institute, and all patients gave informed consent. We studied only patients with chronic stable coronary artery disease; no patient with recent acute myocardial infarction or unstable angina was included in the study. Twelve patients had undergone coronary-artery bypass surgery previously. The patients ranged in age from 26 to 79 years (mean, 58); there were 88 men and 12 women. The selection of patients for this reinjection protocol was performed without knowledge of the patients' coronary anatomy, left ventricular function, or the results of conventional stress-redistribution thallium imaging.

Exercise Thallium SPECT

After an overnight fast, the patients underwent thallium scintigraphy while exercising on a treadmill according to a standardized multistage exercise-test protocol, with continuous monitoring of symptoms, electrocardiogram, heart rate, and blood pressure. During exercise, 64 percent of the patients had an increase in their heart rate to more than 85 percent of the maximal predicted rate. At peak exercise, 2 mCi of thallium-201 was administered intravenously, and the patient continued to exercise for an additional 45 to 60 seconds. Thallium images were then obtained with a wide-field-of-view rotating gamma camera equipped with a high-sensitivity, low-energy, medium-resolution, parallel-hole collimator (Apex 415, APC-3, Elscint, Boston) centered on the 68-keV photo peak with a 20 percent window. The camera was rotated in a 180-degree arc in an elliptical orbit about the patient's thorax from a right-anterior oblique angle of 40 degrees to a left-posterior oblique angle of 40 degrees at 6-degree increments for 30 seconds each. Redistribution images were obtained three to four hours after exercise testing while the patients were resting. Immediately thereafter, all patients received a second injection of 1 mCi of thallium-201, and SPECT was performed within 10 to 15 minutes (reinjection imaging). From the raw scintigraphic data, sagittal, short-axis, and long-axis tomograms were reconstructed as previously described,12 and four consecutive representative slices of each view were selected for interpretation. The reconstructed stress, redistribution, and reinjection images were then analyzed both qualitatively and quantitatively.

Qualitative Thallium Analysis

The distribution of thallium uptake was analyzed qualitatively in the three tomographic views (four slices per view) as follows: the septal, apical, and lateral regions in the long-axis (transaxial) view; the anterior, apical, and inferior regions in the sagittal view; and the anterior, septal, inferior, and lateral regions in the short-axis (oblique) view. The stress, redistribution, and reinjection images were standardized to the maximal myocardial activity in the stress images and paired for simultaneous display: stress and redistribution images, stress and reinjection images, and redistribution and reinjection images. The resulting 300 paired images were displayed in random order and graded by two experienced, blinded observers using a three-point scale, on which 0 indicated markedly reduced or absent activity, 1 definitely reduced activity, and 2 normal activity. The grade assigned to a given region was the lowest regional score from all tomographic slices and views.

Quantitative Thallium Analysis

The thallium images were also analyzed with a semiautomatic quantitative circumferential-profile analysis applied to the short-axis tomograms. Briefly, for each patient, an operator-defined region of interest was drawn around the left ventricular activity of each short-axis slice on the stress images and the corresponding tomograms of the redistribution and reinjection images. The myocardial activity was subdivided into 64 sectors, each emanating from the center of the tomograms. All 64 sectors were of equal arc, which began at 3 o'clock (the middle of the lateral wall) and proceeded counterclockwise (Fig. 1Figure 1Sector Analysis for Assessing the Regional Uptake of Thallium by the Myocardium.). The mean counts per pixel within the myocardial sectors of the redistribution and reinjection images were standardized to the sector with greatest thallium activity in the stress images. To facilitate comparison of these data with the qualitative interpretations, the sectors were then grouped and averaged into four myocardial regions (Fig. 1). Thus, for the 100 patients a total of 400 regions were evaluated.

To determine the normal range for analysis of the quantitative data, we also studied 50 normal subjects (26 men and 24 women) who had no evidence of cardiovascular or pulmonary disease and whose physical examinations, electrocardiograms, and echocardiograms were normal. A myocardial region was considered abnormal in a patient with coronary artery disease if the thallium uptake on the stress image was more than 2 SD below the mean for the same region in the normal subjects of the same sex. Reproducibility studies were performed in 40 patients to determine the precision of measurement for assessing changes in thallium activity in each myocardial region among the stress, redistribution, and reinjection studies. A region with reduced activity on the stress study was considered irreversibly abnormal if the increase in the standardized thallium activity in that region did not exceed the reproducibility limit for that region on subsequent images. Alternatively, a region with reduced activity on the stress study was considered reversibly ischemic if the increase of standardized thallium uptake on the redistribution or reinjection image exceeded the reproducibility limit for that region. Similarly, regional thallium "washout" was defined as a decrease in relative thallium activity between the redistribution and reinjection images that exceeded the reproducibility limit for that region.

Gated Blood-Pool Cardiac Scintigraphy

Radionuclide angiography was performed to assess the left ventricular ejection fraction and regional wall motion at rest, with the use of red cells labeled in vivo with 15 to 20 mCi of technetium-99m. Imaging was performed with a conventional Anger camera equipped with a high-sensitivity parallel-hole collimator, as previously described.13 The left ventricular ejection fraction was derived by computer analysis of the scintigraphic data, and regional wall motion was assessed qualitatively by two experienced observers from the images displayed in cineangiographic format.13 With our technique, the lower limit of normal for the resting ejection fraction is 45 percent, with a reproducibility limit of 4 percent.14 The left ventricular ejection fraction in the 100 patients ranged from 16 to 69 percent (mean, 44± 12 percent) and was below the normal range in 50 patients.

Coronary Arteriography

Cardiac catheterization was performed within one to two weeks of the thallium studies in 85 of the patients and within a mean of six months in the other 15; we used the percutaneous femoral technique. Coronary-artery stenosis and graft patency were assessed by experienced cardiologists without knowledge of the results of thallium exercise testing or radionuclide angiography. Thirty-nine patients had marked narrowing of one vessel, 26 of two vessels, and 35 of three vessels. In patients with bypass grafts, a vessel was considered patent if there was no important narrowing (<50 percent) in the graft or in the native coronary artery distal to the graft anastomosis.

Percutaneous Transluminal Coronary Angioplasty

Twenty of the 100 patients underwent percutaneous transluminal coronary angioplasty according to the procedure initially described by Grüntzig and coworkers.15 Immediate improvement in coronary-artery stenosis was assessed angiographically by measuring the luminal diameter and directly by measuring the transstenotic coronary-artery-pressure gradient. Three to six months after revascularization, these patients again underwent thallium exercise SPECT, radionuclide angiography, and coronary angiography to assess vessel patency.

Statistical Analysis

The quantitative regional uptake of thallium during stress, redistribution, and reinjection imaging, standardized for peak activity during the stress study, was analyzed with the two-tailed paired t-test. The absolute quantitative uptake of thallium in regions with apparent washout as compared with normal regions was analyzed with the two-tailed unpaired t-test.

Results

During thallium exercise testing, perfusion defects developed in 92 of the 100 patients, whereas the remaining 8 patients had homogeneous regional uptake of thallium. Among the 92 patients with exercise-induced defects, a total of 260 myocardial regions (2.6 regions per patient) were graded as abnormal by qualitative analysis, and 259 regions were abnormal by quantitative analysis.

Qualitative Thallium Analysis

Of the 260 myocardial regions that were considered to be abnormal on the stress images, 88 (34 percent) were considered to be completely normal on the conventional redistribution images, and the other 172 (66 percent) were considered to have persistent defects. Eighty-seven of the persistent abnormalities identified by stress imaging were partially reversed on redistribution imaging, and 85 remained irreversible (or "fixed").

After the reinjection of thallium, thallium uptake increased in 42 of the 85 regions with fixed defects (49 percent) — a response suggestive of viable myocardium — and uptake was completely normal in 23 of the 42 regions. An example of the divergent results for the three measurements is shown in Figure 2Figure 2Short-Axis Thallium Tomograms during Stress, Redistribution, and Reinjection Imaging in a Patient with Coronary Artery Disease.: stress imaging and redistribution imaging indicate apparently fixed anterior and septal defects, whereas reinjection imaging indicates normal perfusion in these areas. The 85 fixed defects identified by redistribution imaging were observed in a total of 43 patients, of whom 27 (63 percent) had improved thallium uptake on reinjection imaging. Fixed defects occurred more frequently in patients with left ventricular dysfunction: 31 of the 43 patients (72 percent) had subnormal ejection fractions. Thallium uptake improved on reinjection imaging in 20 of the 31 patients (65 percent).

Of the 87 regions determined by stress imaging to have abnormal perfusion that was only partially reversed on redistribution imaging, 49 (56 percent) had further increases in thallium uptake on reinjection imaging; in fact, 45 of the 49 (92 percent) had normal perfusion. Thus, 101 of the 172 regions with persistent defects that were identified as either fixed or only partially reversible on redistribution imaging demonstrated enhanced thallium uptake on reinjection imaging. Reinjection imaging identified 46 patients with reversible abnormalities of thallium perfusion that would have been considered fixed or only partially reversible on standard redistribution imaging. These results were the same whether or not the patients were studied while taking antianginal medications.

Quantitative Thallium Analysis

Of the 259 myocardial regions identified as having perfusion abnormalities by stress imaging, 115 (44 percent) were identified as having fixed defects by redistribution imaging. Reinjection imaging showed that 46 of the regions with apparently fixed defects (40 percent) had improved or normal thallium uptake, with an increase in mean regional uptake from 58±13 percent during redistribution imaging to 71±13 percent during reinjection imaging. An example of increased regional thallium activity after reinjection imaging in one patient is shown in Figure 3Figure 3Quantitative Analysis of Regional Thallium Activity.. In contrast, in 69 regions identified by reinjection imaging to have persistent defects, the mean regional uptake of thallium remained unchanged (redistribution imaging, 61±14 percent; reinjection imaging, 62±14 percent).

This quantitative method was then applied to the 42 regions with fixed defects according to redistribution-imaging criteria that were judged to be viable after reinjection imaging on the basis of qualitative analysis. Enhanced thallium uptake on reinjection imaging was confirmed by quantitative analysis; the mean regional uptake of thallium increased from 56±12 percent during redistribution imaging to 64±10 percent during reinjection imaging (P<0.001). In contrast, in regions that were judged to have persistent perfusion defects on reinjection imaging on the basis of qualitative analysis, the mean regional uptake of thallium was similar during redistribution imaging and reinjection imaging (46± 14 percent vs. 47±12 percent; P not significant).

Apparent thallium washout between the redistribution and reinjection studies was observed in 27 of the 259 (10 percent) regions initially deemed abnormal. In 13 of these (5 percent), the regional interpretation was changed from reversible on redistribution imaging to fixed on reinjection imaging when compared with the results obtained during stress imaging. This apparent washout was caused by a disproportionate increase in thallium activity on reinjection imaging in the normal regions (51±5 percent increase) as compared with the ischemic regions (34±7 percent increase; P<0.01), producing the appearance of reduced activity in ischemic regions relative to that in normal regions. All 27 regions with apparent washout were served by critically narrowed coronary arteries (>75 percent stenosis); there was total occlusion of 14 regions.

Effects of Coronary Angioplasty

Among the 20 patients studied before and after percutaneous transluminal coronary angioplasty, there were 23 regions with persistent defects on redistribution imaging before angioplasty (either fixed or partially reversible abnormalities), of which 15 (65 percent) had enhanced thallium uptake on reinjection imaging. On repeat imaging three to six months after angioplasty, the uptake of thallium was normal on both stress and redistribution imaging in 13 of these 15 regions. Four of the 15 regions were considered to have completely fixed perfusion defects on redistribution imaging before revascularization; all 4 regions had normal thallium uptake after angioplasty. The improved thallium uptake on stress imaging in these 13 regions after angioplasty was associated with improved regional wall motion at rest on the basis of radionuclide angiography. In contrast, all eight regions with persistent defects on reinjection imaging before angioplasty again demonstrated persistent perfusion defects after angioplasty that were associated with persistent abnormalities in regional wall motion (P<0.001 by chi-square analysis).

Discussion

Thallium scintigraphy has played an important part in distinguishing ischemic from infarcted myocardium in patients with coronary artery disease. Since the uptake of thallium by the myocardial cell is an active process and depends on regional blood flow, it can be used as an index of both regional perfusion and myocardial viability.

In the initial clinical studies with thallium-201, two separate injections were used: one during maximal exercise and the other at rest. Because of the long half-life of thallium-201 and the resultant high levels of residual myocardial activity, the rest and exercise studies were performed one to two weeks apart. In 1977, Pohost and coworkers reported that perfusion defects identified by imaging immediately after exercise may disappear, or the thallium may be "redistributed," if imaging is repeated several hours after the exercise study.16 Several subsequent studies in animals showed that the redistribution noted when imaging was delayed represented an absolute reduction in thallium concentration in the normal segments along with an absolute increase in the concentration in ischemic segments.16 17 18 In clinical studies, initially reduced thallium uptake (after exercise) that is redistributed on images obtained after a delay of three to four hours is considered to represent ischemic myocardium. However, many exercise-induced perfusion defects in ischemic myocardium do not return to normal on redistribution imaging, even when the underlying myocardium is viable rather than infarcted.9 10 11 A possible explanation is that thallium redistribution in a given defect depends not only on the severity of the initial defect, but also on the continuing delivery of thallium over the subsequent three to four hours, as reflected by blood thallium levels. If the blood thallium level remains the same (or increases slightly) during the serial-imaging interval, an apparent defect that is actually viable myocardium should fill in; on the other hand, if the blood level continues to decrease, the delivery of thallium may be insufficient, and the defect may persist even though the underlying myocardium is not infarcted. These latter "irreversible" defects might be reversible if the delivery of thallium were augmented. Therefore, we hypothesized that the reinjection of thallium in patients at rest immediately after conventional redistribution imaging, performed three to four hours after exercise testing, would provide the necessary blood thallium concentration for uptake by viable yet compromised myocardium with apparently irreversible defects.

The reinjection of thallium in our patients significantly improved our ability to detect ischemic but viable myocardium in 49 percent of the regions that were interpreted as having irreversible, fixed abnormalities on redistribution imaging. The reinjection of thallium also enhanced the uptake of the isotope in 56 percent of the regions identified as having partially reversible defects by redistribution imaging. Thus, reinjection imaging identified as viable 101 of the 172 regions that conventional stress—redistribution imaging had identified as having persistent perfusion defects, greatly overestimating the extent and severity of myocardial fibrosis. Although apparent thallium washout was also observed between redistribution imaging and reinjection imaging in 10 percent of the abnormal myocardial regions, the relative washout changed the interpretation of the defects from reversible to fixed in only 5 percent of the regions. This phenomenon appears to be caused by a disproportionately smaller increment in regional thallium activity after reinjection in some ischemic regions as compared with normal regions. Thus, the washout effect reflects the reduction in regional perfusion at rest in regions served by critically stenosed or occluded coronary arteries, rather than differences in the rates of regional thallium clearance. In view of this point, we believe that the term "differential uptake" is preferable to "washout" to describe the phenomenon. Unlike conventional redistribution imaging, in which washout reflects an actual net loss of thallium activity between stress imaging and redistribution imaging, differential uptake after reinjection indicates a smaller accumulation of thallium in abnormal regions than in normal regions.

In 1978, Blood and associates reported discordance between conventional images obtained several hours after exercise and images obtained with thallium injected at rest.19 In their series of patients with coronary artery disease, perfusion defects were present in 56 percent on redistribution imaging, in contrast to only 32 percent on imaging performed after the injection of thallium under resting conditions (P<0.01). In 17 patients with discordant results, 16 had defects on conventional redistribution imaging but not on imaging performed at rest. A similar discordance between images obtained four to five hours after exercise and images obtained after thallium administration at rest was observed by Ritchie and coworkers.20 Kiat and coworkers reported that 61 percent of the segments with fixed defects on conventional delayed imaging demonstrated late redistribution when a third scan was obtained 18 to 72 hours after exercise.11

Our results are in agreement with these studies, in that nearly 50 percent of the regions with fixed defects on conventional redistribution imaging had further uptake of thallium after reinjection imaging at rest. More recently, Brunken and associates reported preservation of metabolic activity, as assessed by [18F]fluorodeoxyglucose uptake on positron-emission tomography, in 47 percent of myocardial segments with fixed defects and 64 percent of segments with partially reversible defects according to redistribution imaging with thallium.21 Our findings after reinjection imaging with thallium are remarkably similar to those obtained by fluorodeoxyglucose imaging, in that 49 percent of the fixed defects and 56 percent of the partially reversible defects identified by conventional redistribution imaging demonstrated enhanced thallium uptake after reinjection imaging at rest. Our conclusion that myocardial regions identified by thallium-reinjection imaging at rest represent viable myocardium is supported in the small subgroup of patients undergoing revascularization by the improvement in regional thallium uptake during exercise after angioplasty and the associated improvement in resting regional wall motion. Given the small number of patients studied after angioplasty, these results of revascularization must be considered preliminary until confirmed by a larger series.

Our results and those of the studies cited demonstrate that conventional redistribution imaging with thallium will incorrectly identify a considerable percentage of myocardial segments as being irreversibly injured. Although other methods have been shown to identify viable myocardium within such "irreversible" defects,11 , 21 there are practical considerations that may limit their routine application. Positron-emission tomography is very expensive and at present not readily available. Thallium imaging performed 18 to 72 hours after exercise is inconvenient, and the quality of the image is often poor. Our results suggest that reinjection imaging with thallium may provide a convenient, efficient, and accurate method of assessing myocardial viability in patients with otherwise fixed defects on thallium imaging in whom invasive interventions are contemplated for myocardial salvage.

We are indebted to Wendy R. Smeltzer and Ray Dextras for excellent technical assistance in the acquisition of the scintigraphic data.

Source Information

From the Cardiology Branch, National Heart, Lung, and Blood Institute, and the Department of Nuclear Medicine, National Institutes of Health, Bethesda, Md. (V.D., N.M.T.F., M.B.L., R.O.B.), and the West Roxbury Veterans Affairs Hospital, West Roxbury, Mass. (T.P.R). Address reprint requests to Dr. Dilsizian at the National Institutes of Health, Bldg. 10, Rm. 7B–15, Bethesda, MD 20892.

References

References

  1. 1

    Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction . Circulation 1982; 66:1146–9.
    CrossRef | Web of Science | Medline

  2. 2

    Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium." J Am Coll Cardiol 1986; 8:1467–70.
    CrossRef | Web of Science | Medline

  3. 3

    Rozanski A, Berman D, Gray R, et al. Preoperative prediction of reversible myocardial asynergy by postexercise radionuclide ventriculography . N Engl J Med 1982; 307:212–6.
    Full Text | Web of Science | Medline

  4. 4

    Brundage BH, Massie BM, Botvinick EH. Improved regional ventricular function after successful surgical revascularization . J Am Coll Cardiol 1984; 3:902–8.
    CrossRef | Web of Science | Medline

  5. 5

    Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography . N Engl J Med 1986; 314:884–8.
    Full Text | Web of Science | Medline

  6. 6

    Dilsizian V, Bonow RO, Cannon RO III, et al. The effect of coronary artery bypass grafting on left ventricular systolic function at rest: evidence for preoperative subclinical myocardial ischemia . Am J Cardiol 1988; 61:1248–54.
    CrossRef | Web of Science | Medline

  7. 7

    Bailey IK, Griffith LS, Rouleau J, Strauss W, Pitt B. Thallium-201 myocardial perfusion imaging at rest and during exercise: comparative sensitivity to electrocardiography in coronary artery disease . Circulation 1977; 55:79–87.
    Web of Science | Medline

  8. 8

    Ritchie JL, Trobaugh GB, Hamilton GW, et al. Myocardial imaging with thallium-201 at rest and during exercise: comparison with coronary arteriography and resting and stress electrocardiography . Circulation 1977; 56:66–71.
    Web of Science | Medline

  9. 9

    Gibson RS, Watson DD, Taylor GJ, et al. Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy . J Am Coll Cardiol 1983; 1:804–15.
    CrossRef | Web of Science | Medline

  10. 10

    Liu P, Kiess MC, Okada RD, et al. The persistent defect on exercise thallium imaging and its fate after myocardial revascularization: does it represent scar or ischemia? Am Heart J 1985; 110:996–1001.
    CrossRef | Web of Science | Medline

  11. 11

    Kiat H, Berman DS, Maddahi J, et al. Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability . J Am Coll Cardiol 1988; 12:1456–63.
    CrossRef | Web of Science | Medline

  12. 12

    O'Gara PT, Bonow RO, Maron BJ, et al. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography . Circulation 1987; 76:1214–23.
    CrossRef | Web of Science | Medline

  13. 13

    Borer JS, Bacharach SL, Green MV, Kent KM, Epstein SE, Johnston GS. Real-time radionuclide cineangiography in the noninvasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary-artery disease . N Engl J Med 1977; 296:839–44.
    Full Text | Web of Science | Medline

  14. 14

    Bonow RO, Kent KM, Rosing DR, et al. Improved left ventricular diastolic filling in patients with coronary artery disease after percutaneous transluminal coronary angioplasty . Circulation 1982; 66:1159–67.
    CrossRef | Web of Science | Medline

  15. 15

    Grüntzig AR, Senning Å, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty . N Engl J Med 1979; 301:61–8.
    Full Text | Web of Science | Medline

  16. 16

    Pohost GM, Zir LM, Moore RH, McKusick KA, Guiney TE, Beller GA. Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201 . Circulation 1977; 55:294–302.
    Web of Science | Medline

  17. 17

    Schwartz JS, Ponto R, Carlyle P, Forstrom L, Cohn JN. Early redistribution of thallium-201 after temporary ischemia . Circulation 1978; 57:332–5.
    Web of Science | Medline

  18. 18

    Beller GA, Watson DD, Ackell P, Pohost GM. Time course of thallium-201 redistribution after transient myocardial ischemia . Circulation 1980; 61:791–7.
    Web of Science | Medline

  19. 19

    Blood DK, McCarthy DM, Sciacca RR, Cannon PJ. Comparison of single-dose and double-dose thallium-201 myocardial perfusion scintigraphy for the detection of coronary artery disease and prior myocardial infarction . Circulation 1978; 58:777–88.
    Web of Science | Medline

  20. 20

    Ritchie JL, Albro PC, Caldwell JH, Trobaugh GB, Hamilton GW. Thallium-201 myocardial imaging: a comparison of the redistribution and rest images . J Nucl Med 1979; 20:477–83.
    Web of Science | Medline

  21. 21

    Brunken RC, Kottou S, Nienaber CA, et al. PET detection of viable tissue in myocardial segments with persistent defects at T1–201 SPECT . Radiology 1989; 172:65–73.
    Web of Science | Medline

Citing Articles (156)

Citing Articles

  1. 1

    James A. Arrighi, Vasken Dilsizian. (2012) Multimodality Imaging for Assessment of Myocardial Viability: Nuclear, Echocardiography, MR, and CT. Current Cardiology Reports
    CrossRef

  2. 2

    James E. Udelson. (2011) Advances in myocardial perfusion imaging. Journal of Nuclear Cardiology
    CrossRef

  3. 3

    Olga Molchanova-Cook, Wengen Chen. (2011) Role of FDG-PET in Evaluation of Myocardial Viability. PET Clinics
    CrossRef

  4. 4

    James E. Udelson. (2011) The ninth annual Mario S. Verani memorial lecture. Journal of Nuclear Cardiology 18:4, 547-560
    CrossRef

  5. 5

    Sara L. Partington, Raymond Y. Kwong, Sharmila Dorbala. (2011) Multimodality imaging in the assessment of myocardial viability. Heart Failure Reviews 16:4, 381-395
    CrossRef

  6. 6

    Ilias Mylonas, Rob S. B. Beanlands. (2011) Radionuclide Imaging of Viable Myocardium: Is it Underutilized?. Current Cardiovascular Imaging Reports 4:3, 251-261
    CrossRef

  7. 7

    Jamshid Shirani, Vasken Dilsizian. (2011) Nuclear cardiac imaging in hypertrophic cardiomyopathy. Journal of Nuclear Cardiology 18:1, 123-134
    CrossRef

  8. 8

    Jennifer L. Hellawell, Kenneth B. Margulies. (2010) Myocardial Reverse Remodeling. Cardiovascular Therapeuticsno-no
    CrossRef

  9. 9

    2010. Diagnostic Techniques in Cardiac Surgery. , 85-127.
    CrossRef

  10. 10

    Udo P. Sechtem, Heiko Mahrholdt. 2010. Myocardial Viability. , 267-283.
    CrossRef

  11. 11

    Kenneth J. Nichols, Andrew Tosh, Christopher J. Palestro. (2009) Prospects for advancing nuclear cardiology by means of new detector designs. Journal of Nuclear Cardiology 16:5, 691-696
    CrossRef

  12. 12

    Zekiye Hasbek, Bulent Turgut, Taner Erselcan, Kenan Yalta, Izzet Tandogan, Gurkan Ozer, Umit Ozdemir, Nergiz Hacer Turgut. (2009) Evaluation of myocardial viability with thallium-201 infusion MPSPECT after oral glucose application in patients with chronic coronary artery disease. Nuclear Medicine Communications 30:10, 779-788
    CrossRef

  13. 13

    Seval Erhamamcı Günel, Ayşegul Akgun. (2009) Comparison of exercise-rest-reinjection Tl-201 imaging and rest sublingual isosorbide dinitrate Tc-99m MIBI imaging for the assessment of myocardial viability. Annals of Nuclear Medicine 23:5, 451-457
    CrossRef

  14. 14

    Evyan Jawad, Rohit Arora. (2008) Chronic Stable Angina Pectoris. Disease-a-Month 54:9, 671-689
    CrossRef

  15. 15

    Shahbudin H. Rahimtoola, Vasken Dilsizian, Christopher M. Kramer, Thomas H. Marwick, Jean-Louis J. Vanoverschelde. (2008) Chronic Ischemic Left Ventricular Dysfunction. JACC: Cardiovascular Imaging 1:4, 536-555
    CrossRef

  16. 16

    Rainer Hoffmann. 2008. Assessment of Viability. , 141-149.
    CrossRef

  17. 17

    Michael Becker, Alexandra Lenzen, Christina Ocklenburg, Katharina Stempel, Harald Kühl, Miria Neizel, Markus Katoh, Rafael Kramann, Joachim Wildberger, Malte Kelm, Rainer Hoffmann. (2008) Myocardial Deformation Imaging Based on Ultrasonic Pixel Tracking to Identify Reversible Myocardial Dysfunction. Journal of the American College of Cardiology 51:15, 1473-1481
    CrossRef

  18. 18

    Srihari S. Naidu, S. Chiu Wong, Richard M. Steingart. (2007) Interventional Therapies for Heart Failure in the Elderly. Heart Failure Clinics 3:4, 485-500
    CrossRef

  19. 19

    Z Tang, M A Diamond, J-M Chen, T A Holly, R O Bonow, A Dasgupta, T Hyslop, A Purzycki, J Wagner, D M McNamara, T Kukulski, S Wos, E J Velazquez, K Ardlie, A M Feldman. (2007) Polymorphisms in Adenosine Receptor Genes are Associated with Infarct Size in Patients with Ischemic Cardiomyopathy. Clinical Pharmacology &#38; Therapeutics 82:4, 435-440
    CrossRef

  20. 20

    Srihari S. Naidu, S. Chiu Wong, Richard M. Steingart. (2007) Interventional Therapies for Heart Failure in the Elderly. Clinics in Geriatric Medicine 23:1, 155-178
    CrossRef

  21. 21

    Rajan AG Patel, George A Beller. (2006) Prognostic role of single-photon emission computed tomography (SPECT) imaging in myocardial viability. Current Opinion in Cardiology 21:5, 457-463
    CrossRef

  22. 22

    Ashraf Hamdan, Nili Zafrir, Alexander Sagie, Ran Kornowski. (2006) Modalities to assess myocardial viability in the modern cardiology era. Coronary Artery Disease 17:6, 567-576
    CrossRef

  23. 23

    Riemer H. J. A. Slart, Jeroen J. Bax, Dirk J. Veldhuisen, Ernst E. Wall, Rudi A. J. O. Dierckx, Pieter L. Jager. (2006) Imaging Techniques in Nuclear Cardiology for the Assessment of Myocardial Viability. The International Journal of Cardiovascular Imaging 22:1, 63-80
    CrossRef

  24. 24

    Clerio F. Azevedo, Susan Cheng, João A. C. Lima. (2005) Cardiac imaging to identify patients at risk for developing heart failure after myocardial infarction. Current Heart Failure Reports 2:4, 183-188
    CrossRef

  25. 25

    Emre Entok, Yuksel Cavusoglu, Eser Kaya, Erkan Vardareli, Bilgin Timuralp. (2005) Detection of hibernate myocardium by 99mTc sestamibi gated SPECT during low-dose dobutamine infusion plus nitrate in patients with first acute myocardial infarction. Nuclear Medicine Communications 26:9, 765-772
    CrossRef

  26. 26

    B. Hesse, K. Tägil, A. Cuocolo, C. Anagnostopoulos, M. Bardiés, J. Bax, F. Bengel, E. Busemann Sokole, G. Davies, M. Dondi, L. Edenbrandt, P. Franken, A. Kjaer, J. Knuuti, M. Lassmann, M. Ljungberg, C. Marcassa, P. Y. Marie, F. McKiddie, M. O’Connor, E. Prvulovich, R. Underwood, B. Eck-Smit. (2005) EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. European Journal of Nuclear Medicine and Molecular Imaging 32:7, 855-897
    CrossRef

  27. 27

    Deval Mehta, Ami E. Iskandrian. (2005) Myocardial Viability: Nuclear Assessment. Echocardiography 22:2, 155-164
    CrossRef

  28. 28

    Gurbir Bhatia, Michael Sosin, John F Leahy, Derek L Connolly, Russell C Davis, Gregory YH Lip. (2005) Hibernating myocardium in heart failure. Expert Review of Cardiovascular Therapy 3:1, 111-122
    CrossRef

  29. 29

    Siu-Sun Yao, Farooq A. Chaudhry. (2005) Assessment of Myocardial Viability with Dobutamine Stress Echocardiography in Patients with Ischemic Left Ventricular Dysfunction. Echocardiography 22:1, 71-83
    CrossRef

  30. 30

    Lawrence G Dembo, Roger Y Shifrin, Steven D Wolff. (2004) MR imaging in ischemic heart disease. Radiologic Clinics of North America 42:3, 651-673
    CrossRef

  31. 31

    Andrew Crean, David Dutka, Richard Coulden. (2004) Cardiac imaging using nuclear medicine and postitron emission tomography. Radiologic Clinics of North America 42:3, 619-634
    CrossRef

  32. 32

    Hua Yang, Min Pu, David Rodriguez, Donald Underwood, Brian P Griffin, Vidyasagar Kalahasti, James D Thomas, Richard C Brunken. (2004) Ischemic and viable myocardium in patients with Non–Q-Wave or Q-Wave myocardial infarction and left ventricular dysfunction. Journal of the American College of Cardiology 43:4, 592-598
    CrossRef

  33. 33

    Howard C. Lewin, Maria G. Sciammarella, Thomas A. Watters, Herbert G. Alexander. (2004) An overview of contemporary nuclear cardiology. Current Cardiology Reports 6:1, 13-19
    CrossRef

  34. 34

    Takuji Toyama, Hiroshi Hoshizaki, Ryotaro Seki, Naoki Isobe, Hitoshi Adachi, Shigeto Naito, Shigeru Oshima, Koichi Taniguchi. (2004) Evaluation of Salvaged Myocardium After Acute Myocardial Infarction Using Single Photon Emission Computed Tomography After 201Tl - Glucose - Insulin Infusion. Circulation Journal 68:4, 348-354
    CrossRef

  35. 35

    &NA;. (2003) Procedure guidelines for radionuclide myocardial perfusion imaging. Nuclear Medicine Communications 24:10, 1105-1119
    CrossRef

  36. 36

    Heiko Mahrholdt, Anja Wagner, Michele Parker, Matthias Regenfus, David S Fieno, Robert O Bonow, Raymond J Kim, Robert M Judd. (2003) Relationship of contractile function to transmural extent of infarction in patients with chronic coronary artery disease. Journal of the American College of Cardiology 42:3, 505-512
    CrossRef

  37. 37

    M. Beheshti, S. Graf, C. Pirich. (2003) Myocardial Perfusion Imaging. Imaging Decisions MRI 7:2, 29-35
    CrossRef

  38. 38

    Harald P. Kühl, Aernout M. Beek, Arno P. van der Weerdt, Mark B.M. Hofman, Cees A. Visser, Adriaan A. Lammertsma, Nicole Heussen, Frans C. Visser, Albert C. van Rossum. (2003) Myocardial viability inchronic ischemic heart disease. Journal of the American College of Cardiology 41:8, 1341-1348
    CrossRef

  39. 39

    J. DE BOER, R. H.J.A. SLART, P. K. BLANKSMA, A. T.M. WILLEMSEN, P. L. JAGER, A. M.J. PAANS, W. VAALBURG, D. A. PIERS. (2003) Comparison of 99mTc-sestamibi-18F-fluorodeoxyglucose dual isotope simultaneous acquisition and rest-stress 99mTc-sestamibi single photon emission computed tomography for the assessment of myocardial viability. Nuclear Medicine Communications 24:3, 251-257
    CrossRef

  40. 40

    Z. PETRASINOVIC, M. OSTOJIC, B. BELESLIN, S. PAVLOVIC, D. SOBIC-SARANOVIC, A. DJORDJEVIC-DIKIC, I. NEDELJKOVIC, S. STOJKOVIC, J. MARINKOVIC, J. STEPANOVIC, M. NEDELJKOVIC, V. VUKCEVIC, A. ARANDJELOVIC, V. OBRADOVIC, V. BOSNJAKOVIC. (2003) Prognostic value of myocardial viability determined by a 201Tl SPECT study in patients with previous myocardial infarction and mild-to-moderate myocardial dysfunction. Nuclear Medicine Communications 24:2, 175-181
    CrossRef

  41. 41

    Farzin Beygui, Claude Le Feuvre, Christophe Maunoury, Gérard Helft, Jean Philippe Metzger. (2002) Coronary vasodilator reserve: a clue to the explanation of 201Tl redistribution patterns early after successful primary stenting for acute myocardial infarction. Journal of the American College of Cardiology 40:5, 877-881
    CrossRef

  42. 42

    S. FUKUOKA, M. MAENO, S. NAKAGAWA, T. FUKUNAGA, H. YAMADA, T. ETO. (2002) Feasibility of myocardial dual-isotope perfusion imaging combined with gated single photon emission tomography for assessing coronary artery disease. Nuclear Medicine Communications 23:1, 19-29
    CrossRef

  43. 43

    Naoko Yasugi, Samon Koyanagi, Keizaburo Ohzono, Kikuo Sakai, Takahiro Matsumoto, Shigeki Sako, Tomoki Homma, Shirou Azakami, Tadayuki Hiroki. (2002) Comparative Study of Dobutamine Stress Echocardiography and Dual Single-Photon Emission Computed Tomography (Thallium-201 and I-123 BMIPP) for Assessing Myocardial Viability After Acute Myocardial Infarction. Circulation Journal 66:12, 1132-1138
    CrossRef

  44. 44

    C. MAUNOURY, S. SÉBAHOUN, C. LE FEUVRE, T. ANTONIETTI, L. BARRITAULT. (2001) Value of linsidomin in assessing myocardial viability with thallium-201 SPECT. Nuclear Medicine Communications 22:12, 1313-1316
    CrossRef

  45. 45

    J. M. GONZÁLEZ, J. CASTELL-CONESA, J. CANDELL-RIERA, J. ROSSELLÓ-URGELL. (2001) Relevance of 99mTc-MIBI rest uptake, ejection fraction and location of contractile abnormality in predicting myocardial recovery after revascularization. Nuclear Medicine Communications 22:7, 795-805
    CrossRef

  46. 46

    Jamshid Shirani, Jaetae Lee, Rebecca Quigg, Ruth Pick, Stephen L Bacharach, Vasken Dilsizian. (2001) Relation of thallium uptake to morphologic features of chronic ischemic heart disease: evidence for myocardial remodeling in noninfarcted myocardium. Journal of the American College of Cardiology 38:1, 84-90
    CrossRef

  47. 47

    Lee, Thomas H., Boucher, Charles A., . (2001) Noninvasive Tests in Patients with Stable Coronary Artery Disease. New England Journal of Medicine 344:24, 1840-1845
    Full Text

  48. 48

    M. PETRETTA, W. ACAMPA, A. CUOCOLO. (2001) Editorial. Nuclear Medicine Communications 22:6, 607-611
    CrossRef

  49. 49

    Purushothaman Kailasnath, Albert J. Sinusas. (2001) Technetium-99m-labeled Myocardial Perfusion Agents: Are They Better than Thallium-201?. Cardiology in Review 9:3, 160-172
    CrossRef

  50. 50

    Hans-Marc J Siebelink, Paul K Blanksma, Harry J.G.M Crijns, Jeroen J Bax, Ad J van Boven, Tsjerk Kingma, D.Albertus Piers, Jan Pruim, Piet L Jager, Willem Vaalburg, Ernst E van der Wall. (2001) No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management. Journal of the American College of Cardiology 37:1, 81-88
    CrossRef

  51. 51

    Vuy Hun Li, Sharmila Dorbala, Dhiraj Narula, Gordon DePuey, Jonathan S. Steinberg. (2001) QT Dispersion and Viable Myocardium in Patients with Prior Myocardial Infarction and Severe Left Ventricular Dysfunction. Annals of Noninvasive Electrocardiology 7:1, 53-59
    CrossRef

  52. 52

    James E Udelson. (2001) Testing our tests: surrogate end points versus driving patient management and outcomes. Journal of the American College of Cardiology 37:1, 89-92
    CrossRef

  53. 53

    Kim, Raymond J., Wu, Edwin, Rafael, Allen, Chen, Enn-Ling, Parker, Michele A., Simonetti, Orlando, Klocke, Francis J., Bonow, Robert O., Judd, Robert M., . (2000) The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction. New England Journal of Medicine 343:20, 1445-1453
    Full Text

  54. 54

    Jagat Narula, Martin S Dawson, Binoy K Singh, Aman Amanullah, Elmo R Acio, Farooq A Chaudhry, Ramin B Arani, Ami E Iskandrian. (2000) Noninvasive characterization of stunned, hibernating, remodeled and nonviable myocardium in ischemic cardiomyopathy. Journal of the American College of Cardiology 36:6, 1913-1919
    CrossRef

  55. 55

    Z. DOĞRUCA, L. KABASAKAL, F. YAPAR, C. NİŞİL, V. A. VURAL, Ç. ÖNSEL. (2000) A comparison of Tl-201 stress-reinjection-prone SPECT and Tc-99m-sestamibi gated SPECT in the differentiation of inferior wall defects from artifacts. Nuclear Medicine Communications 21:8, 719-727
    CrossRef

  56. 56

    Noriyuki Takeyasu, Shigeyuki Watanabe, Iwao Yamaguchi, Kazuhiko Eda, Masahiro Toyama, Kazuhiko Sakamoto, Takumi Saito, Takayoshi Yamanouchi, Takeshi Masuoka, Ryuichi Ajisaka, Tohru Takeda, Yuji Itai, Yasuro Sugishita. (2000) Low-dose dobutamine radionuclide ventriculography for prediction of myocardial viability: Quantitative analysis of regional left ventricular function. Clinical Cardiology 23:6, 409-414
    CrossRef

  57. 57

    Hiroaki Hosokawa, Florence H Sheehan, Takahiko Suzuki. (2000) Measurement of postsystolic shortening to assess viability and predict recovery of left ventricular function after acute myocardial infarction. Journal of the American College of Cardiology 35:7, 1842-1849
    CrossRef

  58. 58

    Jucylea M Cwajg, Eduardo Cwajg, Sherif F Nagueh, Zuo-Xiang He, Usman Qureshi, Leopoldo I Olmos, Miguel A Quinones, Mario S Verani, William L Winters, William A Zoghbi. (2000) End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation. Journal of the American College of Cardiology 35:5, 1152-1161
    CrossRef

  59. 59

    Yasushl Koide, Masayuki Yotsukura, Kazuhiro Tajino, Hideaki Yoshino, Kyozo Ishikawa. (2000) Enhanced detection of ischemic but viable myocardium by qt interval dispersion on treadmill exercise electrocardiograms of patients with healed anterior wall myocardial infarcts. Clinical Cardiology 23:4, 277-284
    CrossRef

  60. 60

    A AKTAS, B CANER. (2000) Immediate thallium re-injection after stress imaging for the detection of myocardial viability. Nuclear Medicine Communications 21:2, 143-146
    CrossRef

  61. 61

    Jose M Mostaza, Marı́a V Gomez, Felix Gallardo, Marı́a L Salazar, Raquel Martı́n-Jadraque, Leandro Plaza-Celemı́n, Isidoro Gonzalez-Maqueda, Luı́s Martı́n-Jadraque. (2000) Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels. Journal of the American College of Cardiology 35:1, 76-82
    CrossRef

  62. 62

    KATHLEEN GALATRO, FAROOQ A. CHAUDHRY. (2000) Prognostic Implications of Myocardial Contractile Reserve in Patients with Ischemic Cardiomyopathy. Echocardiography 17:1, 61-67
    CrossRef

  63. 63

    Thomas H. Marwick. (1999) Use of standard imaging techniques for prediction of postrevascularization functional recovery in patients with heart failure. Journal of Cardiac Failure 5:4, 334-346
    CrossRef

  64. 64

    U. Sechtem, Frank M. Baer, E. Voth, P. Theissen, C.A. Schneider. (1999) Stress functional MRI: Detection of ischemic heart disease and myocardial viability. Journal of Magnetic Resonance Imaging 10:5, 667-675
    CrossRef

  65. 65

    J Arrighi. (1999) Assessment of myocardial viability and its clinical relevance. ACC Current Journal Review 8:5, 77-81
    CrossRef

  66. 66

    Farooq A Chaudhry, Jason T Tauke, Renato S Alessandrini, Gil Vardi, Michele A Parker, Robert O Bonow. (1999) Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. Journal of the American College of Cardiology 34:3, 730-738
    CrossRef

  67. 67

    Pierre Y Marie, Nicolas Danchin, Fabrice Branly, Michaël Angioı̈, Alain Grentzinger, Jean M Virion, Benoit Brouant, Pierre Olivier, Gilles Karcher, Yves Juillière, Faı̈ez Zannad, Alain Bertrand. (1999) Effects of medical therapy on outcome assessment using exercise thallium-201 single photon emission computed tomography imaging. Journal of the American College of Cardiology 34:1, 113-121
    CrossRef

  68. 68

    O. Pereztol, J. F. Batista, J. A. Valdés, L. M. Rochela, F. Sosa, D. López, E. Sánchez, B. Pérez. (1999) Myocardial reversibility detection. Rest NTG99mTc-MIBI versus201TI reinjection. Preliminary results. Journal of Radioanalytical and Nuclear Chemistry 240:2, 489-497
    CrossRef

  69. 69

    Anastasia N Kitsiou, Stephen L Bacharach, Marissa L Bartlett, Gopal Srinivasan, Ronald M Summers, Arshed A Quyyumi, Vasken Dilsizian. (1999) 13N-ammonia myocardial blood flow and uptake. Journal of the American College of Cardiology 33:3, 678-686
    CrossRef

  70. 70

    Eiji Tadamura, Takashi Kudoh, Makoto Motooka, Masayuki Inubushi, Seiji Shirakawa, Naoya Hattori, Tomohisa Okada, Tetsuya Matsuda, Takaaki Koshiji, Kazunobu Nishimura, Katsuhiko Matsuda, Junji Konishi. (1999) Assessment of regional and global left ventricular function by reinjection Tl-201 and rest Tc-99m sestamibi ECG-gated SPECT. Journal of the American College of Cardiology 33:4, 991-997
    CrossRef

  71. 71

    Shahbudin H. Rahimtoola, MB, FRCP, MACP. (1999) CONCEPT AND EVALUATION OF HIBERNATING MYOCARDIUM. Annual Review of Medicine 50:1, 75-86
    CrossRef

  72. 72

    Helmut Baumgartner, Gerold Porenta, Yuk-Kong Lau, Michael Wutte, Ursula Klaar, Mohammad Mehrabi, Robert J Siegel, Johannes Czernin, Günther Laufer, Heinz Sochor, Heinrich Schelbert, Michael C Fishbein, Gerald Maurer. (1998) Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT. Journal of the American College of Cardiology 32:6, 1701-1708
    CrossRef

  73. 73

    Ichiro Matsunari, Guido Böning, Sibylle I Ziegler, Stephan G Nekolla, Jens C Stollfuss, Istvan Kosa, Edward P Ficaro, Markus Schwaiger. (1998) Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using 18F-fluorodeoxyglucose. Journal of the American College of Cardiology 32:4, 927-935
    CrossRef

  74. 74

    Christian A Schneider, Eberhard Voth, Sybille Gawlich, Frank M Baer, Michael Horst, Harald Schicha, Erland Erdmann, Udo Sechtem. (1998) Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after q wave myocardial infarction: importance of infarct location adjusted thresholds. Journal of the American College of Cardiology 32:3, 648-654
    CrossRef

  75. 75

    Richard Underwood. (1998) Imaging modalities for detection of myocardial viability. Magma: Magnetic Resonance Materials in Physics, Biology, and Medicine 6:2-3, 137-139
    CrossRef

  76. 76

    Gianni Mobilia, Pierluigi Zanco, Alessandro Desideri, Gianfilippo Neri, Ferdinando Alitto, Gianleone Suzzi, Franca Chierichetti, Leopoldo Celegon, Giorgio Ferlin, Riccardo Buchberger. (1998) T wave normalization in infarct-related electrocardiographic leads during exercise testing for detection of residual viability. Journal of the American College of Cardiology 32:1, 75-82
    CrossRef

  77. 77

    R Sanderson, S Woldman, G McCurrach, W Martin, I Hutton. (1998) Lung uptake of thallium-201: a marker of defect reversibility?. Physics in Medicine and Biology 43:6, 1469-1479
    CrossRef

  78. 78

    Athanassios Antonopoulos, Evangelos Georgiou, Michael Kyriakidis, Dimitrios Nikolopoulos, Pavlos Toutouzas, Charalambos Proukakis. (1998) Early postexercise thallium-201 reinjection after sublingual nitroglycerin augmentation: Effects on detection of myocardial ischemia and/or viability. Clinical Cardiology 21:6, 419-426
    CrossRef

  79. 79

    LINDA CROUSE. (1998) Advances in Pharmacological Cardiac Stress Testing.. Echocardiography 15:4, 393-399
    CrossRef

  80. 80

    Nili Zafrir, Jeffrey A Leppo, Christopher P Reinhardt, Seth T Dahlberg. (1998) Thallium Reinjection Versus Standard Stress/Delay Redistribution Imaging for Prediction of Cardiac Events. Journal of the American College of Cardiology 31:6, 1280-1285
    CrossRef

  81. 81

    Paul A Bottomley, Robert G Weiss. (1998) Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium. The Lancet 351:9104, 714-718
    CrossRef

  82. 82

    Hiroshi Yoshida, Kazuyuki Sakata, Mamoru Mochiduki, Manabu Shirotani. (1998) Comparison of Filled-in Myocardial Segments After Early and Late Reinjection of Thallium-201. Japanese Circulation Journal 62:3, 178-182
    CrossRef

  83. 83

    (1997) Echocardiography in anesthesia and intensive care medicine I. Acta Anaesthesiologica Scandinavica 41, 267-278
    CrossRef

  84. 84

    Louis S. Constine, Ronald G. Schwartz, Duncan E. Savage, Vernon King, Ann Muhs. (1997) Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease. International Journal of Radiation Oncology*Biology*Physics 39:4, 897-906
    CrossRef

  85. 85

    Pierre-Yves Marie, Michaël Angioï, Nicolas Danchin, Pierre Olivier, Jean M Virion, Alain Grentzinger, Gilles Karcher, Yves Juillière, Daniel Fagret, François Cherrier, Alain Bertrand. (1997) Assessment of Myocardial Viability in Patients With Previous Myocardial Infarction by Using Single-Photon Emission Computed Tomography With a New Metabolic Tracer: [123I]-16-Iodo-3-Methylhexadecanoic Acid (MIHA). Journal of the American College of Cardiology 30:5, 1241-1248
    CrossRef

  86. 86

    Jeroen J Bax, William Wijns, Jan H Cornel, Frans C Visser, Eric Boersma, Paolo M Fioretti. (1997) Accuracy of Currently Available Techniques for Prediction of Functional Recovery After Revascularization in Patients With Left Ventricular Dysfunction Due to Chronic Coronary Artery Disease: Comparison of Pooled Data. Journal of the American College of Cardiology 30:6, 1451-1460
    CrossRef

  87. 87

    Roberto Sciagrà, Gianni Bisi, Giovanni M Santoro, Francesca Zerauschek, Stelvio Sestini, Paola Pedenovi, Ruggiero Pappagallo, Pier Filippo Fazzini. (1997) Comparison of Baseline–Nitrate Technetium-99m Sestamibi With Rest–Redistribution Thallium-201 Tomography in Detecting Viable Hibernating Myocardium and Predicting Postrevascularization Recovery. Journal of the American College of Cardiology 30:2, 384-391
    CrossRef

  88. 88

    Julio A Panza, Joy M Laurienzo, Rodolfo V Curiel, Ellis F Unger, Arshed A Quyyumi, Vasken Dilsizian, Richard O Cannon. (1997) Investigation of the Mechanism of Chest Pain in Patients With Angiographically Normal Coronary Arteries Using Transesophageal Dobutamine Stress Echocardiography. Journal of the American College of Cardiology 29:2, 293-301
    CrossRef

  89. 89

    Susik Kim, Hiroshi Yamabe, Mitsuhiro Yokoyama. (1997) Impaired coronary circulation in acute myocardial infarction: A dipyridamole-thallium-201 study. European Journal of Nuclear Medicine 24:2, 210-214
    CrossRef

  90. 90

    Gérald Vanzetto, Marc Janier, Daniel Fagret, Luc Cinotti, Xavier André-Fouet, Michel Comet, Jacques Machecourt. (1997) Metabolic myocardial viability assessment with iodine 123-16-iodo-3-methylhexadecanoic acid in recent myocardial infarction: Comparison with thallium-201 and fluorine-18 fluorodeoxyglucose. European Journal of Nuclear Medicine 24:2, 170-178
    CrossRef

  91. 91

    Shigeru Fukuzawa, Masayuki Inagaki, Shigeru Morooka, Toshihisa Inoue, Yasunori Matsumoto, Kenichi Yokoyama, Shun Ozawa. (1997) Evaluation of Myocardial Viability Using Sequential Dual-Isotope Single Photon Emission Tomography Imaging With Rest TI-201/Stress Tc-99m Tetrofosmin in the Prediction of Wall Motion Recovery After Revascularization. Japanese Circulation Journal 61:6, 481-487
    CrossRef

  92. 92

    Jeroen J. Bax, Jan H. Cornel, Frans C. Visser, Paolo M. Fioretti, Arthur van Lingen, Ambroos E.M. Reijs, Eric Boersma, Gerrit J.J. Teule, Cees A. Visser. (1996) Prediction of recovery of myocardial dysfunction after revascularization comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. Journal of the American College of Cardiology 28:3, 558-564
    CrossRef

  93. 93

    G.J.R. Cook, M.N. Maisey. (1996) The current status of clinical PET imaging. Clinical Radiology 51:9, 603-613
    CrossRef

  94. 94

    Vasken Dilsizian. (1996) Myocardial viability: Contractile reserve or cell membrane integrity?. Journal of the American College of Cardiology 28:2, 443-446
    CrossRef

  95. 95

    Todd H. Hansen, Dogglas S. Segar. (1996) The use of dobutamine stress echocardiography for the determination of myocardial viability. Clinical Cardiology 19:8, 607-612
    CrossRef

  96. 96

    Jean-Louis J. Vanoverschelde, Anne-Marie D'Hondt, Thomas Marwick, Bernhard L. Gerber, Martine De Kock, Robert Dion, William Wijns, Jacques A. Melin. (1996) Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. Journal of the American College of Cardiology 28:2, 432-442
    CrossRef

  97. 97

    Pijls, Nico H.J., de Bruyne, Bernard, Peels, Kathinka, van der Voort, Pepijn H., Bonnier, Hans J.R.M., Bartunek, Jozef, Koolen, Jacques J., . (1996) Measurement of Fractional Flow Reserve to Assess the Functional Severity of Coronary-Artery Stenoses. New England Journal of Medicine 334:26, 1703-1708
    Full Text

  98. 98

    W. B. Calhoun, Roger M. Mills, Walter E. Drane. (1996) Clinical importance of viability assessment in chronic ischemic heart failure. Clinical Cardiology 19:5, 367-369
    CrossRef

  99. 99

    B. L. F. Eck-Smit, A. F. M. Kuijper, A. H. Zwinderman, A. V. G. Bruschke, E. K. J. Pauwels, E. E. Wall. (1996) Defect reversibility using thallium-201 reinjection. The International Journal of Cardiac Imaging 12:1, 3-10
    CrossRef

  100. 100

    Hitoshi Naruse, Tomohiro Kondo, Tohru Arii, Masato Morita, Mitsumasa Ohyanagi, Tadaaki Iwasaki, Minoru Fukuchi. (1996) Comparative accuracy of various Tl-201 reinjection imaging protocols to detect myocardial viability. Annals of Nuclear Medicine 10:1, 119-126
    CrossRef

  101. 101

    Leslee J. Shaw, Kim A. Eagle, Bernard J. Gersh, D. Douglas Miller. (1996) Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. Journal of the American College of Cardiology 27:4, 787-798
    CrossRef

  102. 102

    Berthe L. F. Eck-Smit, Ernst E. Wall, Patrick P. A. M. Verhoeven, Suzanne Poots, Aeilko H. Zwinderman, Ernest K. J. Pauwels. (1996) Clearance of thallium-201 from the peripheral blood: Comparison of immediate and standard thallium-201 reinjection. European Journal of Nuclear Medicine 23:2, 188-194
    CrossRef

  103. 103

    Jean-Louis J. Vanoverschelde, Bernhard Gerber, Agn??s Pasquet, Jacques A. Melin. (1996) Nuclear and Echocardiographic Imaging for Prediction of Reversible Left Ventricular Ischemic Dysfunction After Coronary Revascularization. Journal of Cardiovascular Pharmacology 28, 27-36
    CrossRef

  104. 104

    Jean-Louis J. Vanoverschelde, Bernhard Gerber, Agnès Pasquet, Jacques A. Melin. (1996) Nuclear and Echocardiographic Imaging for Prediction of Reversible Left Ventricular Ischemic Dysfunction After Coronary Revascularization: Current Status and Future Directions. Journal of Cardiovascular Pharmacology 28, 27-36
    CrossRef

  105. 105

    Junichi Taki, Kenichi Nakajima, Ichiro Matsunari, Hisashi Bunko, Shigeo Takada, Norihisa Tonami, Kinichi Hisada. (1995) Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium: Assessment with iodine-123-labelled beta-methyl-branched fatty acid. European Journal of Nuclear Medicine 22:12, 1385-1392
    CrossRef

  106. 106

    Lee A. Fleisher, Stanley H. Rosenbaum, Ann H. Nelson, Diwaker Jain, Frans J. Th Wackers, Barry L. Zaret. (1995) Preoperative Dipyridamole Thallium Imaging and Ambulatory Electrocardiographic Monitoring as a Predictor of Perioperative Cardiac Events and Long-term Outcome. Anesthesiology 83:5, 906-917
    CrossRef

  107. 107

    I.C. Dormehl, N. Hugo, D. Rossouw, A. White, L.E. Feinendegen. (1995) Planar myocardial imaging in the baboon model with iodine-123-15-(iodophenyl)pentadecanoic acid (IPPA) and iodine-123-15-(P-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP), using time-activity curves for evaluation of metabolism. Nuclear Medicine and Biology 22:7, 837-847
    CrossRef

  108. 108

    Pierre-Yves Marie, Nicolas Danchin, Jean F. Durand, Luc Feldmann, Alain Grentzinger, Pierre Olivier, Gilles Karcher, Yves Juilliére, Jean M. Virion, Daniel Beurrier, François Cherrier, Alain Bertrand. (1995) Long-term prediction of major ischemic events by exercise thallium-201 single-photon emission computed tomography. Journal of the American College of Cardiology 26:4, 879-886
    CrossRef

  109. 109

    Jan -Erik Karlsson, Anders Björkholm, Eva Nylander, Jan Ohlsson, Lars Wallentin. (1995) Additional value of thallium-201 SPECT to a conventional exercise test for the identification of severe coronary lesions after an episode of unstable coronary artery disease. The International Journal of Cardiac Imaging 11:2, 127-137
    CrossRef

  110. 110

    PAOLO MARZULLO, OBERDAN PARODI, GIANMARIO SAMBUCETI, BARBARA REISENHOFER, ALESSIA GIMELLI, ASSUERO GIORGETTI, MONICA BARTOLI, ANTONIO L'ABBATE. (1995) Myocardial Viability: Nuclear Medicine Versus Stress Echocardiography. Echocardiography 12:3, 291-302
    CrossRef

  111. 111

    Daniel S. Berman, Hosen Kiat, John D. Friedman, George Diamond. (1995) Clinical applications of exercise nuclear cardiology studies in the era of healthcare reform. The American Journal of Cardiology 75:11, D3-D13
    CrossRef

  112. 112

    Alberto Margonato, Sergio L. Chierchia, Robert G. Xuereb, Mariosa Xuereb, Gabriele Fragasso, Alberto Cappelletti, Claudio Landoni, Giovanni Lucignani, Ferruccio Fazio. (1995) Specificity and sensitivity of exercise-induced st segment elevation for detection of residual viability: Comparison with fluorodeoxyglucose and positron emission tomography. Journal of the American College of Cardiology 25:5, 1032-1038
    CrossRef

  113. 113

    Nasaraiah Nallamothu, Massroor Ghods, Jaekyeong Heo, Abdulmassih S. Iskandrian. (1995) Comparison of thallium-201 single-photon emission computed tomography and electrocardiographic response during exercise in patients with normal rest electrocardiographic results. Journal of the American College of Cardiology 25:4, 830-836
    CrossRef

  114. 114

    James L. Ritchie, Timothy M. Bateman, Robert O. Bonow, Michael H. Crawford, Raymond J. Gibbons, Robert J. Hall, Robert A. O'Rourke, Alfred F. Parisi, Mario S. Verani, Melvin D. Cheitlin, Arthur Garson, Richard P. Lewis, Thomas J. Ryan, Robert C. Schlant, William L. Winters. (1995) Guidelines for clinical use of cardiac radionuclide imaging report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Society of Nuclear Cardiology. Journal of the American College of Cardiology 25:2, 521-547
    CrossRef

  115. 115

    Carl T Lomboy, Douglas S Schulman, Howard P Grill, Angel R Flores, Judith E Orie, Jerome E Granato. (1995) Rest—redistribution thallium-201 scintigraphy to determine myocardial viability early after myocardial infarction. Journal of the American College of Cardiology 25:1, 210-217
    CrossRef

  116. 116

    Hitoshi Matsuo, Sachiro Watanabe, Yoshio Nishida, Tetsuo Matsubara, Motoo Kano, Shintaro Tanihata, Yukihiko Matsuno, Hiroshi Oda, Yasunori Kotoo, Hiroshige Oohashi, Yoshihiro Uno, Motoyuki Ishiguro. (1994) Identification of asynergic but viable myocardium in patients with chronic coronary artery disease by gated blood pool scintigraphy during isosorbide dinitrate and low-dose dobutamine infusion: Comparison with thallium-201 scintigraphy with reinjection. Annals of Nuclear Medicine 8:4, 283-293
    CrossRef

  117. 117

    James R. Corbett. (1994) Tomographic radionuclide ventriculography: Opportunity ignored?. Journal of Nuclear Cardiology 1:6, 567-570
    CrossRef

  118. 118

    Gianni Bisi, Roberto Sciagrà, Giovanni M. Santoro, Pier Filippo Fazzini. (1994) Rest technetium-99m sestmibi temography in combination with short-term administration of nitrates: Feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. Journal of the American College of Cardiology 24:5, 1282-1289
    CrossRef

  119. 119

    King, Spencer B.Lembo, Nicholas J.Weintraub, William S.Kosinski, Andrzej S.Barnhart, Huiman X.Kutner, Michael H.Alazraki, Naomi P.Guyton, Robert A.Zhao, Xue-Qiao. (1994) A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass Surgery. New England Journal of Medicine 331:16, 1044-1050
    Full Text

  120. 120

    Naonori Ogiu, Kenji Nakai, Katsuhiko Hiramori. (1994) Thallium-201 reinjection images can identify the viable and necrotic myocardium similarly to metabolic imaging with glucose loading18F-fluorodeoxyglucose (18FDG)-PET. Annals of Nuclear Medicine 8:3, 171-176
    CrossRef

  121. 121

    Hirotaka Watada, Hiroshi Ito, Hidemasa Oh, Tohru Masuyama, Masahito Aburaya, Masatsugu Hori, Masaomi Iwakura, Yorihiko Higashino, Kenshi Fujii, Takazo Minamino. (1994) Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction. Journal of the American College of Cardiology 24:3, 624-630
    CrossRef

  122. 122

    John J. Mahmarian, Nancy L. Fenimore, Gary F. Marks, Marilyn J. Francis, Hugo Morales-Ballejo, Mario S. Verani, Craig M. Pratt. (1994) Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: Results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography. Journal of the American College of Cardiology 24:1, 25-32
    CrossRef

  123. 123

    Jacques Machecourt, Philippe Longère, Daniel Fagret, Gérald Vanzetto, Jean E. Wolf, Claude Polidori, Michel Comet, Bernard Denis. (1994) Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. Journal of the American College of Cardiology 23:5, 1096-1106
    CrossRef

  124. 124

    Baron, Jean-FrancoisMundler, OlivierBertrand, MicheleVicaut, EricBarre, EricGodet, GillesSamama, Charles MarcCoriat, PierreKieffer, EdouardViars, Pierre. (1994) Dipyridamole-Thallium Scintigraphy and Gated Radionuclide Angiography to Assess Cardiac Risk before Abdominal Aortic Surgery. New England Journal of Medicine 330:10, 663-669
    Full Text

  125. 125

    Pasquale Perrone-Filardi, Stephen L. Bacharach, Vasken Dilsizian, JoséA. Marin-Neto, Simone Maurea, James A. Arrighi, Robert O. Bonow. (1994) Clinical significance of reduced regional myocardial glucose uptake in regions with normal blood flow in patients with chronic coronary artery disease. Journal of the American College of Cardiology 23:3, 608-616
    CrossRef

  126. 126

    Richard E. Stewart, Jeffrey Popma, Gerald M. Gacioch, Morton Kalus, Sheila Squicciarini, Ziad Al-Aouar, M. Anthony Schork, Markus Schwaiger. (1994) Comparison of thallium-201 SPECT redistribution patterns and rubidium-82 PET rest-stress myocardial blood flow imaging. The International Journal of Cardiac Imaging 10:1, 15-23
    CrossRef

  127. 127

    R. ALEX CASE, ROBERT BUCKMIRE, DAVID P. McLAUGHLIN, MARK KELLER. (1994) Physiological Assessment of Coronary Artery Disease and Myocardial Viability in Ischemic Syndromes Using Adenosine Echocardiography. Echocardiography 11:2, 133-143
    CrossRef

  128. 128

    Hiroshi Yoshida, Kazuyuki Sakata, Mamoru Mochizuki, Tsukasa Kouyama, Yasunori Matsumoto, Mitsuru Takezawa, Masami Yoshimura, Norihisa Ono, Noriko Mori, Shoichi Yokoyama, Tsuneo Hoshino, Tsuneo Kaburagi. (1994) Value of thallium-201 early reinjection for assessment of myocardial viability. Annals of Nuclear Medicine 8:1, 31-40
    CrossRef

  129. 129

    John D.L. Bry, Michael Belkin, Thomas F. O'Donnell, William C. Mackey, James E. Udelson, Christopher H. Schmid, Dana Gelb Safran. (1994) An assessment of the positive predictive value and cost-effectiveness of dipyridamole myocardial scintigraphy in patients undergoing vascular surgery. Journal of Vascular Surgery 19:1, 112-124
    CrossRef

  130. 130

    Phillip Harris. (1993) Post thrombolysis management. Australian and New Zealand Journal of Medicine 23:6, 760-762
    CrossRef

  131. 131

    Andrew Tonkin, Robert Chan. (1993) Reperfusion injury, stunning and myocardial viability. Australian and New Zealand Journal of Medicine 23:6, 756-759
    CrossRef

  132. 132

    Nagara Tamaki, Masahide Kawamoto, Norio Takahashi, Yoshiharu Yonekura, Yasuhiro Magata, Ryuji Nohara, Hirofumi Kambara, Shigetake Sasayama, Kazuo Hirata, Toshihiko Ban, Junji Konishi. (1993) Prognostic value of an increased in flourine-18 deoxyglucose uptake in patients with myocardial infarction: Comparision with stress thallium imaging. Journal of the American College of Cardiology 22:6, 1621-1627
    CrossRef

  133. 133

    John A. Elefteriades, George Tolis, Evelyn Levi, L.Kendrick Mills, Barry L. Zaret. (1993) Coronary artery bypass grafting in severe left ventricular dysfunction: Excellent survival with improved ejection fraction and functional state. Journal of the American College of Cardiology 22:5, 1411-1417
    CrossRef

  134. 134

    Zaret, Barry L.Wackers, Frans J.. (1993) Nuclear Cardiology. New England Journal of Medicine 329:11, 775-783
    Full Text

  135. 135

    Abdulmassih S. Iskandrian, Shung C. Chae, Jaekyeong Heo, Charles D. Stanberry, Valerie Wasserleben, Virginia Cave. (1993) Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. Journal of the American College of Cardiology 22:3, 665-670
    CrossRef

  136. 136

    Vasken Dilsizian, Robert O. Bonow, Stephen E. Epstein, Lameh Fananapazir. (1993) Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. Journal of the American College of Cardiology 22:3, 796-804
    CrossRef

  137. 137

    William D. Suggs, Robert B. Smith, William S. Weintraub, Thomas F. Dodson, Atef A. Salam, John C. Motta. (1993) Selective screening for coronary artery disease in patients undergoing elective repair of abdominal aortic aneurysms. Journal of Vascular Surgery 18:3, 349-357
    CrossRef

  138. 138

    Michael Ragosta, George A. Beller. (1993) The noninvasive assessment of myocardial viability. Clinical Cardiology 16:7, 531-538
    CrossRef

  139. 139

    Elias H. Botvinick. (1993) The proper tool for the job. Journal of the American College of Cardiology 21:6, 1328-1331
    CrossRef

  140. 140

    Edward O. McFalls, Kathie M. Doliszny, Frank Grund, Edward Chute, Elliot Chesler. (1993) Angina and persistent exercise thallium defects: Independent risk factors in elective vascular surgery. Journal of the American College of Cardiology 21:6, 1347-1352
    CrossRef

  141. 141

    Gabriele Fragasso, Alberto Margonato, Sergio L. Chierchia. (1993) Assessment of viability after myocardial infarction. The International Journal of Cardiac Imaging 9:S1, 3-10
    CrossRef

  142. 142

    George A. Beller. (1993) New directions in myocardial perfusion imaging. Clinical Cardiology 16:2, 86-94
    CrossRef

  143. 143

    Donald L. Johnston, Vinod K. Gupta, Richard E. Wendt, John J. Mahmarian, Mario S. Verani. (1993) Detection of viable myocardium in segments with fixed defects on thallium-201 scintigraphy: Usefulness of magnetic resonance imaging early after acute myocardial infarction. Magnetic Resonance Imaging 11:7, 949-956
    CrossRef

  144. 144

    Maurizio Dondi, Flavio Tartagni, Francesco Fallani, Stefano Fanti, Mario Marengo, Italo DiTommaso, Qiu-Fu Zheng, Nino Monetti. (1993) A comparison of rest sestamibi and rest-redistribution thallium single photon emission tomography: Possible implications for myocardial viability detection in infarcted patients. European Journal of Nuclear Medicine 20:1, 26-31
    CrossRef

  145. 145

    Leslee Shaw, D.Douglas Miller, Barbara A. Kong, Thomas Hilton, Art Stelken, Karen Stocke, Bernard R. Chaitman. (1992) Determination of perioperative cardiac risk by adenosine thallium-201 myocardial imaging. American Heart Journal 124:4, 861-869
    CrossRef

  146. 146

    Bruce S. Cutler, Robert C. Hendel, Jeffrey A. Leppo. (1992) Dipyridamole-thallium scintigraphy predicts perioperative and long-term survival after major vascular surgery. Journal of Vascular Surgery 15:6, 972-981
    CrossRef

  147. 147

    Robert J. Gropler, Barry A. Siegel, Kondapuram Sampathkumaran, Julio E. Pérez, Burton E. Sobel, Steven R. Bergmann, Edward M. Geltman. (1992) Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction. Journal of the American College of Cardiology 19:5, 989-997
    CrossRef

  148. 148

    Thomas Reifsnyder, Dennis F. Bandyk, Debra Lanza, Gary R. Seabrook, Jonathan B. Towne. (1992) Use of stress thallium imaging to stratify cardiac risk in patients undergoing vascular surgery. Journal of Surgical Research 52:2, 147-151
    CrossRef

  149. 149

    Seiji Tomiguchi, Mutsumasa Takahashi, Osamu Shimomura, Akihiro Kojima, Masafumi Hara, Yukinori Koga, Kotaro Minoda, Hirofumi Yasue, Kazuya Hayasaki. (1991) Usefulness of reinjection image for evaluating viable myocardium in the infarcted zone on exercise thallium-201 SPECT. Annals of Nuclear Medicine 5:4, 149-155
    CrossRef

  150. 150

    David S. Kayden, Stephen Sigal, Robert Soufer, Jennifer Mattera, Barry L. Zaret, Frans J. Th. Wackers. (1991) Thallium-201 for assessment of myocardial viability: Quantitative comparison of 24-hour redistribution imaging with imaging after reinjection at rest. Journal of the American College of Cardiology 18:6, 1480-1486
    CrossRef

  151. 151

    Andre Syrota, Philippe Jehenson. (1991) Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission. European Journal of Nuclear Medicine 18:11, 897-923
    CrossRef

  152. 152

    Bernard J. Gersh, Charanjit S. Rihal, Thom W. Rooke, David J. Ballard. (1991) Evaluation and management of patients with both peripheral vascular and coronary artery disease. Journal of the American College of Cardiology 18:1, 203-214
    CrossRef

  153. 153

    Thomas H. Marwick, William J. Maclntyre, Ernesto E. Salcedo, Raymundo T. Go, Gopal Saha, Annette Beachler. (1991) Identification of ischemic and hibernating myocardium: Feasibility of post-exercise f-18 deoxyglucose positron emission tomography. Catheterization and Cardiovascular Diagnosis 22:2, 100-106
    CrossRef

  154. 154

    (1991) Reinjection of Thallium after Stress–Redistribution Imaging. New England Journal of Medicine 324:4, 268-270
    Full Text

  155. 155

    Matthew D. Mitchell, Mary Osbakken. (1991) Estimation of myocardial perfusion using deuterium nuclear magnetic resonance. Magnetic Resonance Imaging 9:4, 545-552
    CrossRef

  156. 156

    Pohost, Gerald M., Henzlova, Milena J., . (1990) The Value of Thallium-201 Imaging. New England Journal of Medicine 323:3, 190-192
    Full Text

Letters